Psychopharmacology – A Masters Class 2021 (CME VIDEOS)

Overview

Psychopharmacology – A Masters Class 2021 (CME VIDEOS) is an on-demand digital course offering comprehensive education on psychopharmacologic principles and treatments. This advanced program covers neurobiology, pharmacological treatments across psychiatric conditions, and the interface between medical and psychiatric disorders. Participants gain exposure to expert insights on clinical application for diverse patient populations, including special considerations for women, children, and the elderly.

On-demand psychiatry education — accessible anytime, anywhere.

Agenda

This curriculum includes expert-led discussions and panel sessions focused on contemporary psychopharmacology topics for clinical practice.

• Neurobiology for the Practicing Clinician – Including Ketamine, Cannabinoids, Inflammation, and Hormones — Carl Salzman, MD
• Neuropsychiatry – Interface Between Neurological and Psychiatric Disorders — Martin A. Samuels, MD
• The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease — Charles B. Nemeroff, MD, PhD
• Pharmacological Treatment of Schizophrenia, Prodrome, First Episode, Relapse, and Recovery — Matcheri S. Keshavan, MD
• Panel Discussion — Moderator: Carl Salzman, MD; Panel: Drs. Samuels, Nemeroff, and Keshavan
• Latest Advances and Current Treatment of Bipolar Mania and Bipolar Depression — Ross J. Baldessarini, MD DSc (hon)
• Advances in Treatment for Refractory Depression — Alan F. Schatzberg, MD
• The Latest Tricks of the Trade – What to Do When Nothing Works in the Treatment of Resistant Psychiatric Disorders — Stephan M. Stahl, MD, PhD, DSc (hon)
• Panel Discussion — Moderator: Carl Salzman, MD; Panel: Drs. Baldessarini, Schatzberg, and Stahl
• Anxiety – Treat the Symptoms or Treat the Disorder When First Line Therapies Fail — Stephan M. Stahl, MD, PhD, DSc (hon)
• Evaluation and Pharmacological and CBT Treatment of Sleep Disturbance — John W. Winkelman, MD, PhD
• Effective Use of Stimulants in Psychiatry – Adult ADD, Anti-Depressant Augmentation, and Eating Disorders — John Ratey, MD
• Child and Adolescent Psychopharmacology – Current and Recent Pharmacologic Treatments — Barbara J. Coffey, MD, MS
• Panel Discussion — Moderator: Carl Salzman, MD; Panel: Drs. Winkelman, Sheehan, Ratey, and Coffey
• Pharmacological Treatment of Substance Use Disorders – Opioids, Alcohol and Marijuana — Roger D. Weiss, MD
• Use of Psychotropic Drugs in the Life Cycle of Women – PMS, Pregnancy, Lactation and Menopause — Ariadna Forray, MD
• Geriatric Psychopharmacology – What Every Prescriber Should Know About Treating the Elderly with Medications — Carl Salzman, MD
• Panel Discussion — Moderator: Carl Salzman, MD; Panel: Drs. Forray and Weiss

Learning Objectives

• Evaluate the effects of neurotransmitters and genes on psychotropic drug treatment
• Study the interface between neurology and psychiatry
• Describe the pharmacologic treatment of schizophrenia with particular reference to the prodromal period and first episode
• Outline the emerging theories and treatments of bipolar disorder, depression, treatment-resistant depression, bipolar depression, stress and anxiety disorders
• Discuss the role of psychotropic medications in women’s mental health with emphasis on PMS, pregnancy, nursing, and the postpartum period
• Review the appropriate use of medications in the treatment of sleep disorders
• Access psychopharmacologic treatment of eating disorders
• Summarize the interface between medicine and psychiatric disorders with emphasis on cardiovascular disease and cancer
• Review the appropriate use of stimulants in the treatment of attention and ADHD disorders as well as their use as adjuncts to antidepressant treatment
• Identify psychopharmacologic treatments for borderline personality disorder
• Explain the role of psychopharmacology in the treatment of substance use disorders, focusing on alcohol, opiates, and cannabis
• Recognize when to utilize ECT and TMS for the treatment of depression
• Discuss standard psychopharmacologic treatments that have now been proven ineffective
• Give examples of the latest advances and challenges in treatment approaches for child, adolescent, and geriatric populations

Speakers

• Carl Salzman, MD
• Martin A. Samuels, MD
• Charles B. Nemeroff, MD, PhD
• Matcheri S. Keshavan, MD
• Ross J. Baldessarini, MD DSc (hon)
• Alan F. Schatzberg, MD
• Stephan M. Stahl, MD, PhD, DSc (hon)
• John W. Winkelman, MD, PhD
• John Ratey, MD
• Barbara J. Coffey, MD, MS
• Roger D. Weiss, MD
• Ariadna Forray, MD

Target Audience

This course is designed for psychiatrists, neurologists, geriatric physicians, psychiatric nurse practitioners, psychologists, pharmacists, and other clinicians involved in psychopharmacologic treatment and management. It is suitable for professionals seeking advanced understanding of psychotropic medication use across diverse psychiatric and medical comorbidities.

Why This Topic Matters

Psychopharmacology – A Masters Class 2021 (CME VIDEOS) addresses critical advances and clinical challenges in the field of psychopharmacology within psychiatry. As mental health conditions increasingly overlap with neurological and medical illnesses, this course reinforces the importance of integrated pharmacological knowledge for effective patient care.

MedHub Central provides this specialized resource to enhance clinicians’ expertise and confidence in applying psychiatric pharmacotherapy. This program supports informed decision-making with updated evidence and practical perspectives relevant to psychiatrists, neurologists, and geriatric specialists.